This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 880651
Submitted by lobbyist on: April 29, 2010 12:00:00 AM
Accepted by Registrar on: April 29, 2010 10:46:09 AM
Designated Filer Information
| Miller, Ronnie |
| 2455 Meadowpine Blvd. | |
|
Mississauga, ON, L5N 6L7
|
905-542-5555 |
| Canada |
Organization Information
| Hoffmann-La Roche Ltd. |
| Hoffmann-La Roche Lt. deals with the healthcare system in the prevention, screening,diagnosis, treatment and management of acute and long-term disease and supports leading research and development including clinical research, clinical trials and genetic research. |
| 2455 Meadowpine Blvd. | |
|
Mississauga, ON, L5N 6L7
|
905-542-5555 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| F. Hoffmann-La Roche AG |
grenzacherstrasse 124
4070 Basle, Switzerland |
Phone: 9055425555 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| April 29, 2010 | |
| December 2, 2010 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Economic Development and Trade
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Black, Iain | Minister of Small Business, Technology and Economic Development | April 28, 2010 |
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health Services | April 28, 2010 | |
| Staff of Minister | Minister of Healthy Living and Sport | April 28, 2010 | |
| Minister | Chong, Ida | Minister of Healthy Living and Sport | April 28, 2010 |
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health Services | April 28, 2010 | |
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
Information Technology
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Black, Iain | Minister of Small Business, Technology and Economic Development | April 28, 2010 |
Science and Technology
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Stilwell, Moira | Minister of Advanced Education and Labour Market Development | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Same as corporate
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | August 9, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Stilwell, Moira | Minister of Advanced Education and Labour Market Development | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chong, Ida | Minister of Healthy Living and Sport | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Chong, Ida | Minister of Healthy Living and Sport | April 28, 2010 |
| MLA | Abbott, George | Shuswap | August 11, 2010 |
| MLA | Austin, Robin | Skeena | August 11, 2010 |
| MLA | Bains, Harry | Surrey-Newton | August 11, 2010 |
| MLA | Barisoff, Bill | Penticton | August 11, 2010 |
| MLA | Barnett, Donna | Cariboo-Chilcotin | August 11, 2010 |
| MLA | Bell, Pat | Prince George-Mackenzie | August 11, 2010 |
| MLA | Bennett, Bill | Kootenay East | August 11, 2010 |
| MLA | Black, Dawn | New Westminster | August 11, 2010 |
| MLA | Black, Iain | Port Moody-Coquitlam | August 11, 2010 |
| MLA | Bloy, Harry | Burnaby-Lougheed | August 11, 2010 |
| MLA | Bond, Shirley | Prince George-Valemount | August 11, 2010 |
| MLA | Brar, Jagrup | Surrey-Fleetwood | August 11, 2010 |
| MLA | Cadieux, Stephanie | Surrey-Panorama | August 11, 2010 |
| MLA | Campbell, Gordon | Vancouver-Point Grey | August 11, 2010 |
| MLA | Cantelon, Ron | Parksville-Qualicum | August 11, 2010 |
| MLA | Chandra Herbert, Spencer | Vancouver-West End | August 11, 2010 |
| MLA | Chong, Ida | Oak Bay-Gordon Head | August 11, 2010 |
| MLA | Chouhan, Raj | Burnaby-Edmonds | August 11, 2010 |
| MLA | Coell, Murray | Saanich North and the Islands | August 11, 2010 |
| MLA | Coleman, Rich | Fort Langley-Aldergrove | August 11, 2010 |
| MLA | Conroy, Katrine | Kootenay West | August 11, 2010 |
| MLA | Coons, Gary | North Coast | August 11, 2010 |
| MLA | Corrigan, Kathy | Burnaby-Deer Lake | August 11, 2010 |
| MLA | Dalton, Marc | Maple Ridge-Mission | August 11, 2010 |
| MLA | de Jong, Mike | Abbotsford West | August 11, 2010 |
| MLA | Dix, Adrian | Vancouver-Kingsway | August 11, 2010 |
| MLA | Donaldson, Doug | Stikine | August 11, 2010 |
| MLA | Elmore, Mable | Vancouver-Kensington | August 11, 2010 |
| MLA | Falcon, Kevin | Surrey-Cloverdale | August 11, 2010 |
| MLA | Farnworth, Mike | Port Coquitlam | August 11, 2010 |
| MLA | Fleming, Rob | Victoria-Swan Lake | August 11, 2010 |
| MLA | Foster, Eric | Vernon-Monashee | August 11, 2010 |
| MLA | Fraser, Scott | Alberni-Pacific Rim | August 11, 2010 |
| MLA | Gentner, Guy | Delta North | August 11, 2010 |
| MLA | Hammell, Sue | Surrey-Green Timbers | August 11, 2010 |
| MLA | Hansen, Colin | Vancouver-Quilchena | August 11, 2010 |
| MLA | Hawes, Randy | Abbotsford-Mission | August 11, 2010 |
| MLA | Hayer, Dave | Surrey-Tynehead | August 11, 2010 |
| MLA | Heed, Kash | Vancouver-Fraserview | August 11, 2010 |
| MLA | Hogg, Gordon | Surrey-White Rock | August 11, 2010 |
| MLA | Horgan, John | Juan de Fuca | August 11, 2010 |
| MLA | Horne, Douglas | Coquitlam-Burke Mountain | August 11, 2010 |
| MLA | Howard, Rob | Richmond Centre | August 11, 2010 |
| MLA | Huntington, Vicki | Delta South | August 11, 2010 |
| MLA | James, Carole | Victoria-Beacon Hill | August 11, 2010 |
| MLA | Karagianis, Maurine | Esquimalt-Royal Roads | August 11, 2010 |
| MLA | Krog, Leonard | Nanaimo | August 11, 2010 |
| MLA | Krueger, Kevin | Kamloops-SouthThompson | August 11, 2010 |
| MLA | Kwan, Jenny | Vancouver-Mount Pleasant | August 11, 2010 |
| MLA | Lake, Terry | Kamloops-North Thompson | August 11, 2010 |
| MLA | Lali, Harry | Fraser-Nicola | August 11, 2010 |
| MLA | Lee, Richard | Burnaby-North | August 11, 2010 |
| MLA | Lekstrom, Blair | Peace River South | August 11, 2010 |
| MLA | Les, John | Chilliwack | August 11, 2010 |
| MLA | Letnick, Norm | Kelowna-Lake Country | August 11, 2010 |
| MLA | MacDiarmid, Margaret | Vancouver-Fairview | August 11, 2010 |
| MLA | Macdonald, Norm | Columbia River-Revelstoke | August 11, 2010 |
| MLA | McIntyre, Joan | West Vancouver-Sea to Sky | August 11, 2010 |
| MLA | McNeil, Mary | Vancouver-False Creek | August 11, 2010 |
| MLA | McRae, Don | Comox Valley | August 11, 2010 |
| MLA | Mungall, Michelle | Nelson-Creston | August 11, 2010 |
| MLA | Penner, Barry | Chilliwack-Hope | August 11, 2010 |
| MLA | Pimm, Pat | Peace River North | August 11, 2010 |
| MLA | Polak, Mary | Langley | August 11, 2010 |
| MLA | Popham, Lana | Saanich South | August 11, 2010 |
| MLA | Ralston, Bruce | Surrey-Whalley | August 11, 2010 |
| MLA | Reid, Linda | Richmond East | August 11, 2010 |
| MLA | Routley, Bill | Cowichan Valley | August 11, 2010 |
| MLA | Routley, Doug | Nanaimo-North Cowichan | August 11, 2010 |
| MLA | Rustad, John | Nechako Lakes | August 11, 2010 |
| MLA | Sather, Michael | Maple Ridge-Pitt Meadows | August 11, 2010 |
| MLA | Simons, Nicholas | Powell River-Sunshine Coast | August 11, 2010 |
| MLA | Simpson, Bob | Cariboo North | August 11, 2010 |
| MLA | Simpson, Shane | Vancouver-Hastings | August 11, 2010 |
| MLA | Slater, John | Boundary-Similkameen | August 11, 2010 |
| MLA | Stewart, Ben | Westside-Kelowna | August 11, 2010 |
| MLA | Stilwell, Moira | Vancouver-Langara | August 11, 2010 |
| MLA | Sultan, Ralph | West Vancouver-Capilano | August 11, 2010 |
| MLA | Thomson, Steve | Kelowna-Mission | August 11, 2010 |
| MLA | Thorne, Diane | Coquitlam-Maillardville | August 11, 2010 |
| MLA | Thornthwaite, Jane | North Vancouver-Seymour | August 11, 2010 |
| MLA | Trevena, Claire | North Island | August 11, 2010 |
| MLA | van Dongen, John | Abbotsford South | August 11, 2010 |
| MLA | Yamamoto, Naomi | North Vancouver-Lonsdale | August 11, 2010 |
| MLA | Yap, John | Richmond-Steveston | August 11, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Stilwell, Moira | Minister of Advanced Education and Labour Market Development | April 28, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Same as corporate
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | August 9, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Same as corporate
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | August 9, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Same as corporate
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | August 9, 2010 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Annual provincial Budgets and Budget updates as it relates to the biopharmaceutical industry. Biologics and Genetic Therapies as it relates to policy affecting the review, approval and process of submissions. PTF Recommendations. Creation of pathways for Subsequent Entry Biologics (SEBs) regarding: information and submission requirements for SEBs, and provincial regulations and process for review. Pricing policy as it relates to the Biopharmaceutical industry in BC. Lobbying in regards to Policy and Market Access in the following areas: Pandemic Planning and Anti-Virals, Oncology, Rheumatology, Transplant, Urgent Care, Virology and Clinical Research. Lobbying regarding the general improvement of Biopharmaceutical business environment in BC
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Falcon, Kevin | Minister of Health Services | April 28, 2010 |